Zylox
Latest round
- Series C
Last raised
- Oct 2020
Total raised
- $45M
Investors
- 4
About Zylox
Established in 2012 and based in Hangzhou, China, Zylox operates as a medical device company dedicated to providing cardiovascular medical devices. It has sub-branch offices in Zhuhai, Beijing, and Shanghai. The company has obtained 35 utility model patents and 9 invention patents. The chairman, founder, and CEO of the company, Zhong Zhao graduated from Johns Hopkins University. In July 2021, Zylox was listed on the Hong Kong Stock Exchange. The company mainly provides two product platforms, which are peripheral vascular intervention solution product platform and neurovascular intervention solution full product platform. The main products of peripheral vascular intervention platform are peripheral vascular stent system and PTA balloon dilation catheter. Zylox also provides products in categories such as balloons, stents, accessories, embolization agents, etc. The company has 57 products under research, of which 34 products have been approved for market by NMPA. Zylox is currently expanding into new therapeutic areas, including vascular closure devices.09 million.
Who invested in Zylox
4 investors across 2 rounds
See all investors in Zylox
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Zylox
Who invested in Zylox?
Zylox has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Zylox raised?
Zylox has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Zylox last raise money?
Zylox's most recent round on record is a Series C, in Oct 2020.
What does Zylox do?
Established in 2012 and based in Hangzhou, China, Zylox operates as a medical device company dedicated to providing cardiovascular medical devices.
Where is Zylox headquartered?
Zylox is headquartered in Hangzhou, China.
Which VCs invest in companies like Zylox?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back medical devices & equipment companies at Zylox's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series C
Raising like Zylox? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.